- Home
- NVCR vs LILAK Comparison
NVCR vs LILAK Comparison
Compare NVCR & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- LILAK
- Stock Information
- Founded
- NVCR 2000
- LILAK 2017
- Country
- NVCR Switzerland
- LILAK Bermuda
- Employees
- NVCR N/A
- LILAK N/A
- Industry
- NVCR Medical/Dental Instruments
- LILAK Cable & Other Pay Television Services
- Sector
- NVCR Health Care
- LILAK Telecommunications
- Exchange
- NVCR Nasdaq
- LILAK Nasdaq
- Market Cap
- NVCR 1.9B
- LILAK 1.1B
- IPO Year
- NVCR 2015
- LILAK N/A
- Fundamental
- Price
- NVCR $17.71
- LILAK $6.60
- Analyst Decision
- NVCR Buy
- LILAK Buy
- Analyst Count
- NVCR 6
- LILAK 3
- Target Price
- NVCR $32.83
- LILAK $10.27
- AVG Volume (30 Days)
- NVCR 1.6M
- LILAK 1.1M
- Earning Date
- NVCR 07-24-2025
- LILAK 08-05-2025
- Dividend Yield
- NVCR N/A
- LILAK N/A
- EPS Growth
- NVCR N/A
- LILAK N/A
- EPS
- NVCR N/A
- LILAK N/A
- Revenue
- NVCR $621,711,000.00
- LILAK $4,441,000,000.00
- Revenue This Year
- NVCR $5.56
- LILAK $2.45
- Revenue Next Year
- NVCR $9.19
- LILAK $3.11
- P/E Ratio
- NVCR N/A
- LILAK N/A
- Revenue Growth
- NVCR 18.27
- LILAK N/A
- 52 Week Low
- NVCR $14.17
- LILAK $4.23
- 52 Week High
- NVCR $34.13
- LILAK $10.93
- Technical
- Relative Strength Index (RSI)
- NVCR 51.32
- LILAK 74.11
- Support Level
- NVCR $17.53
- LILAK $5.78
- Resistance Level
- NVCR $18.70
- LILAK $6.53
- Average True Range (ATR)
- NVCR 0.72
- LILAK 0.24
- MACD
- NVCR 0.09
- LILAK 0.09
- Stochastic Oscillator
- NVCR 60.56
- LILAK 96.21
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.